A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909).

MLA

Zheng, Yan, et al. “A Phase III Study on Neoadjuvant Chemotherapy versus Neoadjuvant Toripalimab plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909).” Annals of Translational Medicine, vol. 9, no. 1, Jan. 2021, p. 73. EBSCOhost, https://doi.org/10.21037/atm-20-5404.

APA

Zheng, Y., Liu, X.-B., Sun, H.-B., Xu, J., Shen, S., Ba, Y.-F., Yan, M., Qin, Z., Liu, B.-X., Wang, Z.-F., Liu, S.-L., Zhang, R.-X., Chen, P.-N., Liang, G.-H., Yuan, D., Li, Z.-X., Liu, Q., Wang, H.-R., Li, H.-M., … Xing, W.-Q. (2021). A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909). Annals of Translational Medicine, 9(1), 73. https://doi.org/10.21037/atm-20-5404

Chicago

Zheng, Yan, Xian-Ben Liu, Hai-Bo Sun, Jinliang Xu, Sining Shen, Yu-Feng Ba, Ming Yan, et al. 2021. “A Phase III Study on Neoadjuvant Chemotherapy versus Neoadjuvant Toripalimab plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909).” Annals of Translational Medicine 9 (1): 73. doi:10.21037/atm-20-5404.